July 22 Could Ignite a Financial Nightmare

He said “a major reckoning is coming” 3 months before 2025’s crash… his work pointed to the Covid crash 25 days before stocks bottomed… and his firm spends $8 million a year in search of the biggest declines in the stock market. Now – one man has a chilling warning for the financial system on July 22.

Tue, July 22 at 10:00AM ET
 
 
 
 

Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

3 Crude Oil Stocks to Load up on for 2016

The direction in crude oil prices could bounce to $79 or it could fall below $10. These three stocks to buy are all but sure to gain from an increase in oil.

Why It’s Time to Buy Campbell’s Stock (CPB)

Campbell's is one of the steadiest stocks around, and with these key metrics improving, Campbell's stock is a buy

Why GigaPower Is Important for the Future of AT&T Stock

AT&T has aggressively upped the rollout of GigaPower nationwide, which could have big implications for T stock price long-term.

Big Spending Has Boeing Co (BA) Stock Set Up for a BIG 2016

Boeing stock looked good on fundamentals alone, and now BA is dumping even more cash on shareholders. Shares look like a great bet for 2016.

63 Trades to Kick Off the Week

During these busy times, it pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start.

The 6 Best Dividend Stocks to Buy in 2016

Another year of disappointing gains and high volatility? Forget it. Investors should retool for 2016 by buying the best dividend stocks on the market.

Has Bank of America Finally Gotten Its Act Together? (BAC)

BAC stock may not have soared on the mixed news, but it's still a decided victory for long-term Bank of America shareholders.

Buy JetBlue (JBLU) Stock as it Continues Its Ascent

JetBlue (JBLU) stock is ripping higher this year as it smartly leverages low fuel costs and expands its market strategy.

AA Stock: It’s Time to Buy Alcoa!

Alcoa stock has been battered in 2015, just like most commodities. But unlike the others, it has huge potential.

3 of the Biggest Values in Energy Stocks Today

Finding value in energy stocks means keeping an eye on debt.

4 Big Moves That Could Transform Amazon.com, Inc. (AMZN)

Amazon stock has an insane valuation, but it has plenty of catalysts to continue boosting the kind of future growth worth justifying its enormous price-earnings ratio.

Another GREAT Quarter From Adobe Systems Incorporated Stock! (ADBE)

Adobe (ADBE) stock is gaining ground after a stellar quarter characterized by strong growth in the cloud. Still, shares remain attractive.

YHOO Stock Is a Buy Regardless of What’s Divested

With a slew of options and loads of unlocked value, YHOO is a must-buy. Here's a look at the different options it has.

How Management Can Push IBM Stock Much Higher in 2016

IBM stock could soar in 2016, but management must do this one thing if it wants to restore investors' faith.

5 Stocks You MUST Watch in 2016

Here’s a peek at five stocks to watch as we head into 2016 -- four bullish and one bearish -- because I believe they’ll play out favorably regardless of what the Fed decides.

Chipotle Mexican Grill, Inc.: Why CMG Stock Is a Brewing Value

Chipotle stock may look screwed, but CMG is a value in the making. Go long CMG shares now.

TWTR Is Showing Ads to Logged-Off Users; Time to Buy Twitter Stock

Twitter stock will surge as advertisements to logged-out users ramp up and the revenues start to climb.

Equifax Is Your Stability In a Sea Of Volatility: EFX Stock

Equifax is a solid company, and EFX stock is in a unique position to thrive regardless of market performance or the economy in general.

Biotech Stocks That Could Double in 2016: Celldex Therapeutics (CLDX)

Celldex Therapeutics (CLDX) is primed for a boffo 2016 as Rintega's FDA approval, CDX-011's data and a cheap stock will cause CLDX stock to double.